Pages that link to "Q33818499"

The following pages link to Molecular modeling and computer aided drug design. Examples of their applications in medicinal chemistry (Q33818499):

Displaying 25 items.

• Current and novel therapeutic molecules and targets in Alzheimer's disease (Q26798231) (← links)
• NMR spectroscopy and protein structure determination: applications to drug discovery and development. (Q30350628) (← links)
• Preliminary study on application of impregnated synthetic peptide TLC stationary phases for the pre-screening of 5-HT1A ligands. (Q30970850) (← links)
• Developing and validating predictive decision tree models from mining chemical structural fingerprints and high-throughput screening data in PubChem (Q33371987) (← links)
• MyMolDB: A micromolecular database solution with open source and free components (Q33950571) (← links)
• Sanjeevini: a freely accessible web-server for target directed lead molecule discovery (Q34530633) (← links)
• Conditional probabilistic analysis for prediction of the activity landscape and relative compound activities (Q34968105) (← links)
• 4D-QSAR: perspectives in drug design. (Q37775506) (← links)
• Per aspera ad astra: application of Simplex QSAR approach in antiviral research (Q37855903) (← links)
• Receptor-dependent 4D-QSAR analysis of peptidemimetic inhibitors of Trypanosoma cruzi trypanothione reductase with receptor-based alignment. (Q38959546) (← links)
• Comparative analysis of L-sorbose dehydrogenase by docking strategy for 2-keto-L-gulonic acid production in Ketogulonicigenium vulgare and Bacillus endophyticus consortium (Q39449745) (← links)
• Rapid activity prediction of HIV-1 integrase inhibitors: harnessing docking energetic components for empirical scoring by chemometric and artificial neural network approaches (Q39675574) (← links)
• Towards a systematic characterization of the antiprotozoal activity landscape of benzimidazole derivatives (Q39831556) (← links)
• Analogue-based approaches in anti-cancer compound modelling: the relevance of QSAR models. (Q41104504) (← links)
• Chronic oral LOAEL prediction by using a commercially available computational QSAR tool (Q43513381) (← links)
• Progress toward virtual screening for drug side effects. (Q44125156) (← links)
• Testing and validation of the Automated Topology Builder (ATB) version 2.0: prediction of hydration free enthalpies (Q51118133) (← links)
• Integrating statistical and experimental protocols to model and design novel Gemini surfactants with promising critical micelle concentration and low environmental risk (Q51556935) (← links)
• Genome and genomics of schistosomes (Q56145238) (← links)
• Theoretical studies of the electronic and structural features of the fragments of dihydropholate reductase inhibitors (Q56982532) (← links)
• Bioinformatics: A rational combine approach used for the identification and in-vitro activity evaluation of potent β-Glucuronidase inhibitors (Q60046647) (← links)
• Theoretical Study of Molecular Structure and Physicochemical Properties of Novel Factor Xa Inhibitors and Dual Factor Xa and Factor IIa Inhibitors (Q60286954) (← links)
• Hierarchical QSAR technology based on the Simplex representation of molecular structure (Q80642889) (← links)
• Computer-aided drug design platform using PyMOL (Q82324131) (← links)
• Methodologies in Spectral Tuning of DSSC Chromophores through Rational Design and Chemical-Structure Engineering (Q91809033) (← links)